Managers / Q4 2024 · view latest →
Cove Street Capital, LLC
CIK 0001531612 · 525 SOUTH DOUGLAS STREET, SUITE 225, EL SEGUNDO, CA, 90245 · 424-221-5897
Summary
Cove Street Capital, LLC reported $86M in U.S.-listed holdings across 94 positions for Q4 2024.
Its largest position, RSSS, represents 8.5% of the portfolio.
Compared with Q3 2024, the fund opened 6 new positions and exited 11.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 86.5% · $74M
- Other · 10.0% · $9M
- ETP · 1.7% · $1M
- ADR · 1.2% · $1M
- REIT · 0.4% · $317,706
- Other · 0.2% · $187,729
Quarter-over-Quarter Changes full breakdown →
vs Q3 2024 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| BMTABRITISH AMERN TOB PLC | NEW | +28.9K | 28.9K | +$1M | $1M |
| TGTREDEGAR CORP | NEW | +1.8K | 1.8K | +$14,047 | $14,047 |
| CTGOCONTANGO ORE INC | NEW | +1.4K | 1.4K | +$13,567 | $13,567 |
| SIFSIFCO INDS INC | NEW | +3.0K | 3.0K | +$10,607 | $10,607 |
| IIIVI3 VERTICALS INC | NEW | +237 | 237 | +$5,460 | $5,460 |
| UTMUTAH MED PRODS INC | NEW | +87 | 87 | +$5,348 | $5,348 |
| CLARCLARUS CORP NEW | ADDED | +192.1K | 297.4K | +$866,581 | $1M |
| ANGI1EURANGI INC | ADDED | +5.8K | 10.0K | +$5,821 | $16,549 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q4 2024
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q3 2025 | $77M | 96 | Nov 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $68M | 97 | Aug 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $64M | 98 | May 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $86M | 94 | Feb 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | Under review | 99 | Nov 12, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | Under review | 84 | Jul 18, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $316M | 105 | May 7, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $327M | 103 | Feb 14, 2024 | RESTATEMENT | changes · EDGAR ↗ |
| Q3 2023 | $296M | 113 | Nov 9, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | Under review | 113 | Aug 11, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $335,356 | 116 | May 5, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | Under review | 113 | Feb 10, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $358M | 112 | Nov 8, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $397M | 118 | Aug 12, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $565M | 122 | May 2, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $571M | 126 | Feb 11, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $674M | 125 | Nov 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $691M | 123 | Aug 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $698M | 120 | May 25, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $565M | 114 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $528M | 111 | Nov 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $505M | 112 | Aug 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $488M | 135 | May 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $756M | 135 | Feb 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $715M | 128 | Nov 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $775M | 129 | Aug 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $817M | 128 | May 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $773M | 130 | Feb 13, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.